Viewing Study NCT04710056


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-05-23 @ 10:04 AM
Study NCT ID: NCT04710056
Status: AVAILABLE
Last Update Posted: 2025-11-14
First Post: 2021-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access to REGN4461 for Patients With Lipodystrophy or Monogenic Obesity With Complications of Leptin Deficiency or Deficient Leptin Signaling
Sponsor: Regeneron Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lipodystrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leptin (LEP) View
None Leptin Receptors (LEPR) View